News

EDINBURGH, Scotland and HOPKINTON, Mass., Feb. 28, 2023 /PRNewswire/ -- RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the addition ...
EDINBURGH, UK AND HOPKINTON, MA, 4 August 2022 – RoslinCT, a cell and gene therapy Contract Development and Manufacturing Organisation (‘CDMO’) developing life-changing therapies in ...
The newly formed organization is equipped with 22 cGMP cell therapy processing suites in Edinburgh and Hopkinton, MA (the home of Lykan Bioscience), and will offer a range of services, including ...
Gov. Maura Healey visited RoslinCT USA in Hopkinton to discuss her proposed $1 billion, 10-year reauthorization of the Life Sciences Initiative.
EDINBURGH, Scotland and HOPKINTON, Mass., Feb. 28, 2023 /PRNewswire/ -- RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the addition ...
EDINBURGH, UK AND HOPKINTON, MA, 4 August 2022 – RoslinCT, a cell and gene therapy Contract Development and Manufacturing Organisation (‘CDMO’) developing life-changing therapies in ...
EDINBURGH, Scotland and HOPKINTON, Mass., Feb. 28, 2023 /PRNewswire/ -- RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the addition ...
EDINBURGH, Scotland and HOPKINTON, Mass., Feb. 28, 2023 /PRNewswire/ -- RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the addition ...
EDINBURGH, Scotland and HOPKINTON, Mass., Feb. 28, 2023 /PRNewswire/ -- RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the addition ...
EDINBURGH, Scotland and HOPKINTON, Mass., Feb. 28, 2023 /PRNewswire/ -- RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the addition ...
EDINBURGH, Scotland and HOPKINTON, Mass., Feb. 28, 2023 /PRNewswire/ -- RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the addition ...